Clinical Trial

CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation

Recruiting
View on ClinicalTrials.gov →
Summary
This trial evaluates the effectiveness of CardioHeartConnect, an eight-week mobile cardiac rehabilitation intervention using Peloton fitness modules, compared to educational control among patients recovering from transcatheter aortic valve replacement (TAVR). The study aims to improve physical activity, functional capacity, quality of life, and cardiovascular health using wearable devices and a digital engagement platform. A total of 200 patients will be recruited from the UCHealth Structural Heart and Valve Clinic and randomized to either CardioHeartConnect or CardioHeartEd. Participants will be assessed at baseline, 8 weeks, and 12 months using surveys, smartwatch data, and electronic health records.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-04; most recent amendment 2025-08-27.
Status change: Not Yet Recruiting → Recruiting 2025-08-27
Trial Details
NCT Number NCT07008911
Lead Sponsor University of Colorado, Denver
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Aortic Valve Stenosis, Aortic Valve Disease
Enrollment 200 participants
Start Date 2025-08-29
Primary Completion 2029-08-01 (estimated)
Study Completion 2029-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-03